The danger of diazoxide in the neonatal intensive care unit
Background: The most common cause of persistent hypoglycemia in infancy is hyperinsulinemic hypoglycemia. When conservative measures fail, providers often use medications to treat persistent hypoglycemia. Diazoxide is first-line therapy for neonatal hypoglycemia and works by inhibiting insulin secre...
Saved in:
Main Authors: | Jay Desai (Author), Logan Key (Author), Alyson Swindall (Author), Kan Gaston (Author), Ajay J. Talati (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
by: Shoshana Newman-Lindsay, et al.
Published: (2022) -
Necrotizing enterocolitis following diazoxide therapy for persistent neonatal hypoglycemia
by: Christina M. Theodorou, et al.
Published: (2020) -
Diazoxide toxicity with hypoglycemia in infants with trisomy 13
by: Mitsuhide Nagaoka, et al.
Published: (2021) -
Management and short-term outcomes of neonates born to mothers with active perinatal SARS-CoV-2 infection
by: Vineet Lamba, et al.
Published: (2021) -
Discharge against Medical Advice at Neonatal Intensive Care Unit in Gujarat, India
by: Bhanu Devpura, et al.
Published: (2016)